Banner
Banner

CompanyPrint
Company documents    

Attention: open in a new window.

Statute
Rules of the Management Board of Genomed S.A.
By-laws of the Supervisory Board of Genomed S.A.
The Regulations of the General Assembly of Genomed S.A.

Company Data

Genomed joint-stock company
Company registered by the District Court for the city of Warszawa in Warszawa,13th Commercial Division, National Court Register No. 0000374741
Share capital PLN 132 130.10
Vat No. PL7010083563
REGON 141108082
Address Poland, Warsaw, 02-971, ul. Ponczowa 12
Phone +48 22 644 60 19
email This e-mail address is being protected from spambots. You need JavaScript enabled to view it


Account No.
BGŻ BNP Paribas S.A. 56 1600 1374 0003 0052 0282 6001
IBAN: PL56 1600 1374 0003 0052 0282 6001
BIC/SWIFT CODE: PPAB PLPK

EURO Account No.
BGŻ BNP Paribas S.A. 71 1600 1374 0003 0052 0282 6022
IBAN: PL71 1600 1374 0003 0052 0282 6022
BIC/SWIFT CODE: PPAB PLPK

USD Account No.

BGŻ BNP Paribas S.A.  98 1600 1374 0003 0052 0282 6021
IBAN: PL98 1600 1374 0003 0052 0282 6021
BIC/SWIFT CODE: PPAB PLPK

Management Board

Anna Boguszewska-Chachulska, Chief Executive Officer cv
Marek Zagulski cv
Andrzej Pałucha cv

Manner of Representation

The Company may be represented by either two members of the board of directors that act jointly or a member of the board of directors acting jointly with an authorized person.

Supervisory board

Bogusław Bobula cv
Tomasz Bykowski cv
Mieczysław Prószyński - chairman of the Supervisory Board cv
Piotr Mariusz Skowron cv
Jakub Swadźba cv
 

Shareholders


Shareholders No of Shares      No of Voices            %of stock %of voices
Diagnostyka sp. z o.o.
562 984
562 984
42,61% 28,81%
Marek Zagulski 274 470
536 470
20,77%
27,46%
Anna Boguszewska – Chachulska 119 210
228 710
 9,02%  11,71%
Andrzej Pałucha  74 000 148 000  5,60%  7,57%
Iwona Wach  74 000 148 000  5,60%  7,57%
Andrzej Migdalski  65 498 129 498  4,96%  6,63%
other series A1 actions  63 195
112 195
 4,78%  5,74%
series A2 actions 35 916 35 916 2,72% 1,84%
other series B actions  52 028
 52 028
 3,94%  2,66%


The share capital creates  1.219.000 shares of series A and 102.301 shares of series B, a total of 1.321.301.
The nominal value of each share is PLN 0.10.

odwiedź nas na facebooku
© Copyright by Genomed S.A. Wykonanie: Delta Interactive